Information PortalData Portal

Data Matrix

Tools & Workflows

Documentation

narlaprevir (Compound)

Description: A compound in the knowledge graph

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View narlaprevir's neighborhood in the knowledge graph.

Knowledge Graph Assertions

	Source	Relation	Target	Evidence
Loading results...

DISPLAY PER PAGE

Report a bug

Data & Metadata

Tools & Use Cases

@CFDE Workbench 2024

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Data & Metadata

Tools & Use Cases

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2024

Knowledge Graph Assertions

	Source	Relation	Target	Evidence
	narlaprevir Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	TFPI2 Gene (Entity type)	-0.00395937
	narlaprevir Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	DHRS2 Gene (Entity type)	0.0032871205
	narlaprevir Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	SCGB2A2 Gene (Entity type)	-0.0040271794
	narlaprevir Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	GPER1 Gene (Entity type)	-0.005201668
	narlaprevir Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	CXCL13 Gene (Entity type)	0.0032537857
	narlaprevir Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	S100A9 Gene (Entity type)	0.0037844034
	narlaprevir Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	SNAP25 Gene (Entity type)	-0.0054187602
	narlaprevir Compound (Entity type)	In similarity relationship with Knowledge Graph Relation (Entity type)	3-isopropyl-5-(4-((6-(4-(methylsulfonyl)phenyl)pyridin-3-yloxy)methyl)piperidin-1-yl)-1,2,4-oxadiazole Compound (Entity type)	0.2818394899368286
	narlaprevir Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	MT1G Gene (Entity type)	-0.003467168
	narlaprevir Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	ASS1 Gene (Entity type)	-0.0043084826

narlaprevir
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
TFPI2
Gene (Entity type)
-0.00395937

narlaprevir
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
DHRS2
Gene (Entity type)
0.0032871205

narlaprevir
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
SCGB2A2
Gene (Entity type)
-0.0040271794

narlaprevir
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
GPER1
Gene (Entity type)
-0.005201668

narlaprevir
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
CXCL13
Gene (Entity type)
0.0032537857

narlaprevir
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
S100A9
Gene (Entity type)
0.0037844034

narlaprevir
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
SNAP25
Gene (Entity type)
-0.0054187602

narlaprevir
Compound (Entity type)
In similarity relationship with
Knowledge Graph Relation (Entity type)
3-isopropyl-5-(4-((6-(4-(methylsulfonyl)phenyl)pyridin-3-yloxy)methyl)piperidin-1-yl)-1,2,4-oxadiazole
Compound (Entity type)
0.2818394899368286

narlaprevir
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
MT1G
Gene (Entity type)
-0.003467168

narlaprevir
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
ASS1
Gene (Entity type)
-0.0043084826

DISPLAY PER PAGE